Art market offers investors ‘escape’ from volatile stocks, Christie’s CEO says

Art market offers investors ‘escape’ from volatile stocks, Christie’s CEO says


A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.

The art market is about to face its biggest test since the November elections, with more than $1 billion of work coming under the hammer in New York next week.



Source

Ticketmaster parent Live Nation reaches settlement with Department of Justice over antitrust concerns
Business

Ticketmaster parent Live Nation reaches settlement with Department of Justice over antitrust concerns

Signs are seen at the Live Nation NYC headquarters on May 23, 2024 in New York City.  Michael M. Santiago | Getty Images Live Nation Entertainment has reached a settlement with the Department of Justice over antitrust concerns surrounding its Ticketmaster platform, a senior DOJ official said Monday. The settlement would see Ticketmaster unwind some […]

Read More
Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More